June is Alzheimer’s & Brain Awareness Month! This is a good time to reflect on the many challenges and inequities facing people of color in the United States when it comes to Alzheimer’s Disease, dementia, and brain health. Sadly, U.S. Latinos are 1.5 times more likely to develop Alzheimer’s disease than whites. Latino caregivers experience high levels of stress when supporting their family members with the disease. Let’s use #SaludTues on Tuesday, June 7, 2022, to tweet about the latest data, strategies, and programs to prevent and reduce Alzheimer’s disease and promote better brain health among Latinos and all people! WHAT: #SaludTues: How to Address Alzheimer’s in the Latino Community
TIME/DATE: 1-2 p.m. EST (Noon-1 p.m. CST), Tuesday, June 7, 2022
...
Doctors often have implicit, subconscious preferences for white patients over those of color, studies show. This is implicit bias. These biases — stereotypes that affect our understanding and decisions about others beyond our conscious control — lead to discrimination and health disparities. To address this issue, you’re invited to join us for "Overcoming Implicit Bias in the Doctor’s Office and Research Studies," at 2 p.m. CT on April 25, 2022. This is the third webinar of a new series, “Let’s Address Health Equity Together.” This Zoom webinar will feature guest speakers to help health care professionals understand implicit bias, “rewire” it toward compassion for patients and research participants of color and engage local leaders in implementing implicit bias ...
March is Colorectal Cancer Awareness Month. This cancer can affect anyone, but older Latinos may be particularly at risk. Know the facts about colorectal cancer, tips for screening and preventions, and how we can help researchers studying cancer.
What Should I Know About Colorectal Cancer?
Colorectal cancer is the disease of the colon and/or rectum. “Most cases of colorectal cancer occur in people ages 45 and older, but the disease is increasingly affecting younger people. Each year, about 150,000 Americans are diagnosed with this disease and more than 50,000 die,” according to the Colorectal Cancer Alliance. Many people in the early stages of colorectal cancer do not experience symptoms. However, symptoms might develop later on in the disease. Mayo Clinic lists ...
The National Institute of Aging (NIA) is seeking comments and suggestions on how it can implement community-based research networks to increase diversity in clinical trials for Alzheimer’s disease and related dementias (ADRD). At Salud America!, we believe that diverse representation is critical in Alzheimer's clinical trials to ensure that health and medical discoveries are equitable for diverse populations. This means increasing diversity among research leaders and clinical trial participants and establishing sustainable connections with Latino communities and other communities of color who have historically been underrepresented in medicine. If you agree, you can endorse Dr. Amelie Ramirez’s comment to NIA. Responses will be accepted through Saturday April 9, ...
Latinos are a dynamic, diverse, rising population. But cancer threatens the future health of the U.S. Latino population. This is why our Salud America! team at the Institute for Health Promotion Research (IHPR) at UT Health San Antonio created a new video, "Latino Cancer: ¿Sabía Usted? (Did You Know?)," to describe the state of Latino cancer disparities and highlight the inequities behind them. The video debuted at the 2022 Advancing the Science of Cancer in Latinos conference. "The conference helped focus on a key underlying issue – health equity. Health equity is where everyone has a fair, just opportunity to be their healthiest," said Dr. Amelie G. Ramirez, leader of the conference and director of Salud America! and the IHPR. "True change starts when we focus on solving ...
Clinical trials have led to the development of better treatments, life-saving medicines, and new prevention strategies for many cancer types. Still, historically, clinical trials have low representation among Latinos and other people of color. We need diverse representation in cancer clinical trials to ensure that health and medical discoveries are equitable for diverse populations. To promote clinical trials, let’s use #SaludTues on Tuesday, April 5, 2022, to discuss cancer clinical trials, why they are so important, and how we all can step up to increase diversity and equitable cancer research, in honor of National Minority Health Month in April. WHAT: #SaludTues Tweetchat: How to Encourage and Achieve Diversity in Cancer Clinical Trials
TIME/DATE: 1-2 ...
With 1 in 3 Latinos facing a cancer diagnosis in their lifetime, UT Health San Antonio is hosting the 2022 Advancing the Science of Cancer in Latinos in-person conference on Feb. 23-25 at the Westin Riverwalk, 420 W. Market St, in San Antonio, Texas. The biennial conference is expected to draw 200 researchers, oncologists, physicians, community leaders, and students for an open dialogue on research advancements and actions to translate basic research into clinical best practices, effective community interventions, system-change advocacy, and professional training to eliminate cancer disparities in Latinos. The first Advancing the Science of Cancer in Latinos conferences in 2018 and 2020 united 80 guest speakers and over 600 attendees from 25 states, from D.C and New York to ...
Living with a cognitive disease is difficult because of how it impacts you and those around you. It can create a stigma, which prevents people from seeking help. This stigma can be worse for Latinos, who face cultural barriers and are often affected by these disorders at a high rate. That’s why physicians like Dr. Gus Alva are trying to help Latinos heal from diseases like Parkinson’s. He teamed up with Acadia Pharmaceuticals and StoryCorps nonprofit for the “Yours, Truly” campaign, a bilingual effort to use multicultural storytelling to bring awareness to the non-motor symptoms of Parkinson’s disease. “This campaign is quite important because it really lends to the public an opportunity of being able through storytelling to convey some very important information ...
Omega 3 fatty acids are essential nutrients. Studies show omega 3 fish oil—which contains both docosahexaenoic acid (DHA) and eicosapentaenoic acid—may help lower blood pressure, slow the development of plaque in the arteries, and reduce the likelihood of heart attack and stroke. With the rising popularity of omega 3 fish oil supplements, researchers are conducting clinical trials to test their benefits for other health issues. This is why Dr. Andrew Brenner and his team at UT Health San Antonio are seeking volunteers for his clinical trial to explore of how omega 3 fatty acids can impact postmenopausal breast cancer patients. “Fish oil supplements with omega 3 fatty acids have been shown to stop or slow down the growth and development of breast cancer cells in ...
